Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acromegaly”

201 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 201 results

Large-scale testing (Phase 3)Ended earlyNCT00765323
What this trial is testing

Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly

Who this might be right for
Acromegaly
Endo Pharmaceuticals 169
Large-scale testing (Phase 3)Study completedNCT01137682
What this trial is testing

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 198
Not applicableLooking for participantsNCT06949891
What this trial is testing

KETOgenic Diet Therapy in Patients With ACROmegaly

Who this might be right for
Acromegaly Due to Pituitary AdenomaKetogenic DietMediterranean Diet
Erasmus Medical Center 60
Post-approval studies (Phase 4)Study completedNCT01618513
What this trial is testing

Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target

Who this might be right for
Acromegaly
University of Aarhus 84
Testing effectiveness (Phase 2)Study completedNCT00001860
What this trial is testing

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

Who this might be right for
AcromegalyPituitary Neoplasm
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5
Post-approval studies (Phase 4)Study completedNCT01794793
What this trial is testing

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Who this might be right for
Cushing's DiseaseAcromegalyNeuroendocrine Tumors+6 more
RECORDATI GROUP 337
Post-approval studies (Phase 4)Study completedNCT00376064
What this trial is testing

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 20
Not applicableUnknownNCT01902420
What this trial is testing

Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly

Who this might be right for
Acromegaly
TC Erciyes University 80
Testing effectiveness (Phase 2)Study completedNCT03548415
What this trial is testing

Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

Who this might be right for
Acromegaly
Ionis Pharmaceuticals, Inc. 43
Not applicableStudy completedNCT01261000
What this trial is testing

Tissue Biomarker for Pegvisomant Action

Who this might be right for
Acromegaly
Cedars-Sinai Medical Center 8
Not applicableStudy completedNCT01819883
What this trial is testing

Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly

Who this might be right for
Acromegaly
Massachusetts General Hospital 40
Not applicableUnknownNCT02854228
What this trial is testing

PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon

Who this might be right for
Pituitary Tumor
Hospices Civils de Lyon 1,300
Testing effectiveness (Phase 2)Study completedNCT02611336
What this trial is testing

Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy

Who this might be right for
Acromegaly Cardiomyopathy
Andrea M. Isidori 15
Large-scale testing (Phase 3)Study completedNCT00234572
What this trial is testing

Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly

Who this might be right for
Acromegaly
Ipsen 108
Large-scale testing (Phase 3)UnknownNCT03252353
What this trial is testing

Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly

Who this might be right for
Acromegaly
Chiasma, Inc. 56
Large-scale testing (Phase 3)Study completedNCT00616551
What this trial is testing

Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients

Who this might be right for
Acromegaly
Ambrilia Biopharma, Inc. 65
Testing effectiveness (Phase 2)UnknownNCT00993356
What this trial is testing

Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas

Who this might be right for
Acromegaly
Shanghai Jiao Tong University School of Medicine 96
Large-scale testing (Phase 3)Study completedNCT02952885
What this trial is testing

Strict IGF-1 Control in Acromegaly

Who this might be right for
Acromegaly
Unity Health Toronto 10
Not applicableStudy completedNCT04138537
What this trial is testing

Olfactory Function and Olfactory Bulb Volume in Acromegaly Patients

Who this might be right for
AcromegalyOlfactory Disorder
Bezmialem Vakif University 40
Not applicableStudy completedNCT05431803
What this trial is testing

Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China

Who this might be right for
Acromegaly
Ipsen 129
Load More Results